The UK's medicines industry is one of the country's leading manufacturing sectors, with exports worth around £30bn.

The Partnership aims to ensure that the UK continues to be an attractive place for this high-value industry to secure exports, provide high skilled job opportunities and increase productivity. 

MMIP is an expert group under the direction of the Life Sciences Council. 

MMIP Structure 

Working closely with key government organisations including the Medicines and Healthcare products Regulatory Authority (MHRA), UK Trade and Investment (UKTI), Innovate UK and the Office for Life Sciences (OLS), MMIP is continuously working to sustain the UK's leading position in medicines manufacturing technologies, including those related to advanced therapy medicinal products (ATMPs), continuous production and digitalisation. 

Work of MMIP

MMIP is divided into six areas of focus.  

MMIP also works to build the medicines manufacturing community.  


MMIP is supported by the ABPI, the BioIndustry Association (BIA) and the Knowledge Transfer Network, and includes leadership from Allergan Biologics, AstraZeneca, Eisai, FUJIFILM Diosynth Biotechnologies, GlaxoSmithKline, Pfizer and ReNeuron

Contact Us 

For more information please contact the MMIP Operations Team: 

You can keep up to date via Twitter #MMIP, or by following@ABPI_UK or @BIA_UK or by joining our LinkedIn group.